Turkish Journal of Medical Sciences
Volume 51

Number 3

Article 42

1-1-2021

Clinical predictors of drug-resistant epilepsy in children
PAKİZE KARAOĞLU
ULUÇ YİŞ
AYŞE İPEK POLAT
MÜGE AYANOĞLU
AYŞE SEMRA HIZ

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KARAOĞLU, PAKİZE; YİŞ, ULUÇ; POLAT, AYŞE İPEK; AYANOĞLU, MÜGE; and HIZ, AYŞE SEMRA (2021)
"Clinical predictors of drug-resistant epilepsy in children," Turkish Journal of Medical Sciences: Vol. 51:
No. 3, Article 42. https://doi.org/10.3906/sag-2010-27
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss3/42

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Medical Sciences

Turk J Med Sci
(2021) 51: 1249-1252
© TÜBİTAK
doi:10.3906/sag-2010-27

http://journals.tubitak.gov.tr/medical/

Research Article

Clinical predictors of drug-resistant epilepsy in children
1,

2

2

2

2

Pakize KARAOĞLU *, Uluç YİŞ , Ayşe İpek POLAT , Müge AYANOĞLU , Semra HIZ 
Pediatric Neurology Clinic, University of Health Sciences Dr. Behçet Uz Child Disease and Pediatric Surgery Training and Research
Hospital, İzmir, Turkey
2
Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey

1

Received: 03.10.2020

Accepted/Published Online: 18.02.2021

Final Version: 28.06.2021

Background/aim: In up to 20% of epilepsy patients, seizures may not be controlled despite the use of antiepileptic drugs, either alone
or in combination. These individuals are considered to have drug-resistant epilepsy. Drug-resistant epilepsy is usually associated with
intellectual disability, psychiatric comorbidity, physical injury, sudden unexpected death, and low quality of life. Early detection and
prediction of drug-resistant epilepsy are essential in determining the patient’s most appropriate treatment option. This retrospective
study aimed to determine the clinical, electroencephalographic, and radiological factors associated with medically intractable childhood
seizures.
Materials and methods: Data regarding 177 patients diagnosed with drug-resistant epilepsy were compared with 281 patients with
drug-responsive epilepsy.
Results: Univariate analysis showed that age at seizure onset, having mixed seizure types, history of status epilepticus, history of neonatal
seizures, history of both having febrile and afebrile seizures, daily seizures at the onset, abnormality on the first electroencephalogram,
generalized epileptic abnormality on electroencephalogram, abnormal neurodevelopmental status, abnormal neuroimaging, and having
symptomatic etiology were significant risk factors for the development of drug-resistant epilepsy (p < 0.05). In multivariable analysis,
having mixed seizure types, history of status epilepticus, having multiple seizures in a day, intellectual disability, symptomatic etiology,
and neuroimaging abnormality remained significant predictors for developing drug-resistant epilepsy.
Conclusions: In the course of childhood epilepsy, some clinical features may predict the outcome. Early identification of patients with
high risk for drug-resistant epilepsy will help plan the appropriate treatment option. Further prospective studies should confirm these
findings.
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1. Introduction
In most patients with epilepsy, seizures respond well to
antiepileptic medication. Although antiepileptic drugs
(AEDs) are used either alone or in combination, epileptic
seizures cannot be controlled in 10%–20% of patients
[1,2]. Although drug-resistant epilepsy patients constitute
a minor part of the patients with epilepsy, they suffer
from the significant psychosocial and economic burden
of the disease and require considerable time and effort
from the physician. Drug-resistant epilepsy has generally
been associated with intellectual disability, psychiatric
comorbidity, physical damage, sudden unexpected death,
and low quality of life [3]. Children with refractory
epileptic seizures use multiple antiepileptic drugs for
long term, which may negatively affect their cognitive
and physical development [3]. Early prediction of drug-

resistant epilepsy may enable patients to be evaluated
earlier in terms of alternative treatments such as ketogenic
diet, epilepsy surgery, or vagal nerve stimulation. Providing
patients with appropriate treatment in a timely manner
may prevent the development of comorbidities associated
with drug-resistant epilepsy [1,3].
This study aimed to determine the clinical,
electroencephalographic, and radiological factors
associated with intractable childhood seizures.
2. Materials and methods
This retrospective study was carried out at Dokuz Eylül
University Faculty of Medicine, Department of Pediatric
Neurology. The institutional ethics committee approved
the study. Families of all participants gave informed
consent before the study. The study included patients
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with epilepsy who were followed up for at least 2 years.
Clinical data were obtained from patient’s medical records.
Patient’s sex, age, age at onset of seizures, seizure type at
the onset, initial seizure frequency, multiple seizures per
day, etiology, previous history of status epilepticus, history
of febrile and neonatal seizures, family history, mental and
motor development, electroencephalogram abnormalities,
brain magnetic resonance imaging (MRI) findings, specific
epileptic syndromes, and behavioral problems were noted.
Epilepsy was defined as two or more unprovoked
seizures. Drug-resistant and drug-responsive epilepsy were
determined according to the International League against
Epilepsy (ILAE) definition. Drug-resistant epilepsy was
defined as the failure of adequate trials of two tolerated and
appropriately chosen and used AED schedules (whether
as monotherapy or in combination) to achieve sustained
seizure freedom. Drug-responsive epilepsy was defined as
epilepsy in which the patient receiving the current AED
regimen has been seizure-free for a minimum of three
times the longest preintervention interseizure interval or
12 months, whichever is longer [4]. Records of the patients
with drug-resistant epilepsy and drug-responsive epilepsy
were reviewed to identify the variables associated with
seizure intractability.
Data were processed and analyzed using SPSS software.
Descriptive statistics, the Pearson chi-squared test,
likelihood ratios, continuity corrections, and the Fisher
exact test were used to analyze data where applicable. The
level of significance was set at p < 0.05. Finally, all variables
demonstrating a significant association with outcomes
were entered into a logistic regression model to determine
independent predictors of intractable epilepsy.

3. Results
There were 458 epileptic children (210 female and 248
male) with a mean age of 7.73 ± 4.72 years. The patients with
at least two years of the follow-up period were included in
the study. The median follow-up time of the patients was
46 months (range: 28–126 months). One hundred seventyseven of them had drug-resistant epilepsy, and 281 had
drug-responsive epilepsy. The high number of patients
with drug-resistant epilepsy can be explained by the fact
that our center is a tertiary pediatric neurology center
where resistant epilepsy cases are referred.
Sex and family history of seizures were not significantly
different between the two groups. There was no statistically
significant difference between drug-resistant epilepsy
and drug-responsive epilepsy groups in terms of focal,
generalized, and unknown onset seizure frequency.
A comparison of the two groups regarding
clinical factors revealed several statistically significant
differences (Table 1). Univariate analysis showed that
age at seizure onset, having mixed seizure types, history
of status epilepticus, history of neonatal seizures,
history of both having febrile and afebrile seizures,
daily seizures at the onset, abnormality on the first
electroencephalogram, generalized epileptic abnormality
on electroencephalogram, abnormal neurodevelopmental
status, abnormal neuroimaging, and having symptomatic
etiology were significant risk factors for the development
of drug-resistant epilepsy (p < 0.05).
Specific epileptic syndromes were detected in 43
patients (24%) in the drug-resistant group. These
syndromes were Ohtaraha syndrome (n = 2), West
syndrome (n = 28), Dravet syndrome (n = 7), LennoxGastaut syndrome (n = 2), Landau Kleffner Syndrome (n

Table 1. Clinical features of patients.
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Clinical factors

Drug-resistant
epilepsy (n =177)

Drug-responsive
epilepsy (n = 281)

p-value

Age of onset

Mean: 1.85 years

Mean: 4.92years

<0.001

Mixed seizure type

28 (16%)

6 (2%)

<0.001

History of status epilepticus

50 (28%)

6 (2%)

<0.001

History of neonatal seizure

41 (23%)

23 (8%)

<0.001

History of both febrile and afebrile seizures

48 (27%)

32 (11%)

<0.001

Multiple seizures in a day

148 (83%)

54 (19%)

<0.001

Epileptiform discharge on initial EEG

172 (97%)

217 (77%)

<0.001

Generalized epileptic abnormality on EEG

59 (33%)

50 (18%)

<0.001

MRI abnormality

134 (76%)

108 (38%)

<0.001

Symptomatic etiology

153 (86%)

124 (44%)

<0.001

Intellectual disability

156 (88%)

102 (36%)

<0.001

Motor retardation

124 (70%)

72 (26%)

<0.001
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= 2), and progressive myoclonic epilepsy (Lafora disease
in one patient and neuronal ceroid lipofuscinosis in one
patient).
In multivariable analysis, having mixed seizure types,
history of status epilepticus, having multiple seizures in
a day, intellectual disability, symptomatic etiology, and
MRI abnormality remained significant predictors for
developing drug-resistant epilepsy (Table 2).

excitatory circuits [12].
Patients with physical and intellectual disabilities were
reported to have less probability of gaining seizure control
than patients with idiopathic epilepsy [12]. A previous
study from Turkey comparing 200 children with refractory
epilepsy and 208 children with well-controlled epilepsy
have stated mental and motor retardation as independent
risk factors for drug-resistant epilepsy [8]. Similarly,
in our study, intellectual disability was associated with
refractoriness of seizures.
In most previous studies, symptomatic etiology has
been reported as a significant risk factor for drug-resistant
epilepsy [1,8,11,13]. The changed structure of the central
nervous system and function leads to hyperexcitability as
the cause of epilepsy. Brain lesions result in neuronal death
and reactive gliosis [14]. One of the mechanisms of drugresistant epilepsy is the transporter hypothesis. According
to this hypothesis, the structural abnormalities damage the
capillary endothelial cells that constitute the blood-brain
barrier, leading to the overexpression of efflux transports
and drug resistance [14]. In our study, 86% of our cases
with refractory seizures had symptomatic etiology,
significantly higher than the drug-responsive group.
Epileptic patients with structural brain abnormalities
have a lower chance of entering remission compared with
structurally normal brains [12]. Previous studies revealed
abnormal MRI findings as a predictor of refractoriness
[8,15]. In our study, MRI abnormalities were significantly
higher in children with drug-resistant epilepsy.
In conclusion, this retrospective study highlights the
factors predicting drug resistance in childhood epilepsy.
Our study indicated strong univariate associations with
several predictive factors. Moreover, our research points
out that having mixed seizure types, history of status
epilepticus, having multiple seizures in a day, intellectual
disability, symptomatic etiology, and MRI abnormality
are independent predictors of drug-resistant childhood
epilepsy. One limitation of this study involves its
methodology. This study is retrospective and should be
verified with prospective studies.

4. Discussion
Several clinical features can be identified in the course
of childhood epilepsy that may predict the outcome.
Early prediction of drug-resistant epilepsy will guide
determining the most appropriate treatment option for the
patient. Several previous studies have reported factors that
may predict drug-resistant epilepsy [5–8]. To the best of
our knowledge, our study is the largest to be performed on
a population of Turkish children with epilepsy.
Having mixed seizure types was identified as a risk
factor for drug-resistant epilepsy in most studies [5,7,8].
Previous studies have also stated that seizure types have an
essential effect on prognosis, and children with multiple
seizure types may have worse outcomes [5–8]. Similarly,
in our research, mixed seizure types were an independent
risk factor for refractoriness.
In our study, the history of status epilepticus predicted
drug resistance. Status epilepticus results from less
inhibition and hyperexcitability, and as status epilepticus
lasts longer, gamma-aminobutyric acid (GABA)-ergic
function declines, and excitatory input continues,
contributing to neuronal death [9]. However, some
studies suggest that status epilepticus is not related to
refractoriness [10]. The reason for conflicting results may
be that status epilepticus can occur both as a result and a
cause of drug-resistant epilepsy [7].
Like in our study, in most studies, initial seizure
frequency was identified as a risk factor for drug resistance
[7,8,10,11]. Repeated seizures have been shown to
produce neuronal loss and mossy fiber sprouting in the
hippocampus, which may cause the forming of recurrent

Table 2. Independent risk factors after logistic regression analysis.
B

SE

OR

95% CI

p-value

Mixed seizure types

1.62

0.58

3.19

0.99–10.24

0.03

History of status epilepticus

1.92

0.53

5.09

1.71–15.09

0.01

Multiple seizures in a day

2.17

0.30

10.85

5.73–20.53

0.00

Intellectual disability

1.72

0.36

3.90

1.49–10.18

0.00

Symptomatic etiology

1.04

0.48

2.27

0.78–6.64

0.03

MRI abnormality

1.03

0.12

1.91

0.72–5.05

0.00

B: beta coefficient, SE: standard error, OR: odds ratio, CI: confidence interval.
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